Exponent (NASDAQ:EXPO – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, October 24th. Analysts expect Exponent to post earnings of $0.48 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Exponent (NASDAQ:EXPO – Get Free Report) last posted its earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. The business had revenue of $132.43 million for the quarter, compared to analysts’ expectations of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.50 EPS. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Stock Performance
EXPO opened at $114.53 on Thursday. The stock has a market capitalization of $5.81 billion, a P/E ratio of 57.84 and a beta of 0.66. The company’s 50-day simple moving average is $108.45 and its two-hundred day simple moving average is $98.81. Exponent has a 52-week low of $64.61 and a 52-week high of $115.75.
Exponent Announces Dividend
Insiders Place Their Bets
In other Exponent news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total transaction of $415,380.00. Following the sale, the vice president now owns 28,422 shares in the company, valued at approximately $2,984,310. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is owned by company insiders.
Analysts Set New Price Targets
Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.
View Our Latest Report on Exponent
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Stock Market Sectors: What Are They and How Many Are There?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What Are the FAANG Stocks and Are They Good Investments?
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.